Evidence map›Paper›PMID 42644137›Full record

ArticleNeuro-oncology advances

Neuronal precursor cell persistence in ganglioglioma is associated with extracellular matrix remodeling and immune cell infiltration.

Jan Kueckelhaus, Lucas Hoffmann, Joëlle A Menstell, David Niklas Zimmer, Jasim Kada-Benotmane, Junyi Zhang, Juergen Beck, Oliver Schnell, Roman Sankowski, Philipp Sievers and 3 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Ras-MAPK somatic variants in mesial temporal lobe epilepsy.Current opinion in genetics & development · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jan KueckelhausDepartment of Neurosurgery, Uniklinikum Erlangen, Friedrich-Alexander Universität-Erlangen-Nürnberg, Erlangen, Germany.ORCID https://orcid.org/0000-0002-4211-4386
Lucas HoffmannDepartment of Neuropathology, Uniklinikum Erlangen, Friedrich-Alexander Universität-Erlangen-Nürnberg, Erlangen, Germany.ORCID https://orcid.org/0000-0002-3801-1595
Joëlle A MenstellMicroenvironment and Immunology Research Laboratory, Medical Center - University of Freiburg, Freiburg, Germany.
David Niklas ZimmerMicroenvironment and Immunology Research Laboratory, Medical Center - University of Freiburg, Freiburg, Germany.
Jasim Kada-BenotmaneMicroenvironment and Immunology Research Laboratory, Medical Center - University of Freiburg, Freiburg, Germany.
Junyi ZhangMicroenvironment and Immunology Research Laboratory, Medical Center - University of Freiburg, Freiburg, Germany.
Juergen BeckDepartment of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany.
Oliver SchnellDepartment of Neurosurgery, Uniklinikum Erlangen, Friedrich-Alexander Universität-Erlangen-Nürnberg, Erlangen, Germany.ORCID https://orcid.org/0000-0002-1284-1427
Roman SankowskiInstitute of Neuropathology, University of Freiburg, Freiburg, Germany.
Philipp SieversDepartment of Neuropathology, University Medical Center Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0003-3237-6021
Felix SahmDepartment of Neuropathology, University Medical Center Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0001-5441-1962
Daniel DelevDepartment of Neurosurgery, Uniklinikum Erlangen, Friedrich-Alexander Universität-Erlangen-Nürnberg, Erlangen, Germany.ORCID https://orcid.org/0000-0001-9444-0178
Dieter Henrik HeilandDepartment of Neurosurgery, Uniklinikum Erlangen, Friedrich-Alexander Universität-Erlangen-Nürnberg, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gangliogliomas (GGs) are low-grade glioneuronal tumors that frequently present with drug-resistant epilepsy. Although their indolent course contrasts with their high epileptogenic potential, the oncogenic mechanisms sustaining neuronal precursor-like populations within the tumor microenvironment remain poorly defined. Methods: We performed spatial transcriptomic profiling on eight histologically confirmed GGs and matched healthy cortex to map the cellular and molecular architecture of the tumor microenvironment. Integrated analysis with weighted gene correlation network analysis (WGCNA) defined recurrent oncogenic programs and spatially resolved tumor-stroma interactions. Results: Eight conserved gene modules emerged, encompassing physiological cortical, reactive glial, and oncopathological programs. The latter captured extracellular matrix (ECM) remodeling, vascular-immune signaling, and persistence of immature, proliferative neuronal-like states. Spatial modeling revealed that these oncopathological programs form structured niches at the tumor-brain interface, where radial glia-derived neuronal-like tumor cells coexist with immune and stromal elements engaged in ECM turnover and cytokine signaling. Conclusions: Ganglioglioma represents a hybrid glioneuronal neoplasm in which developmental neuronal programs are co-opted by tumor-associated stromal and immune cues. This convergence establishes a permissive oncogenic niche that sustains precursor-like tumor cells and provides a mechanistic basis for both the tumor's benign growth and its intrinsic epileptogenicity.

Indexed as

epilepsygangliogliomaspatial transcriptomicsstem cell

Identifiers

PMID42644137
PMCPMC13505631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.